CVS stock: why CVS Health will split off its drugstores by 2028

What happened. On November 4 CVS Health said it intends to separate into two independent, publicly traded companies. The decision follows a strategic review by its board of directors (CVS Health press release). The Financial Times reported the plan first, on Tuesday, CNBC says.

Who gets what. The first company will hold Aetna, CVS Caremark, CVS Specialty, Oak Street Health and Signify Health. For now it will be called CVS Health. The second will be named CVS Pharmacy: about 9,000 pharmacies, mail pharmacy, MinuteClinic (including virtual care) and the Health100 technology business. Caremark is a pharmacy benefit manager (PBM): it negotiates drug prices for insurers and employers.

Who leads. David Joyner, now Chairman and CEO of CVS Health, will lead the first company. Prem Shah, now Group President of CVS Health, will be CEO of CVS Pharmacy. Other leaders and board members will be named later.

Timing and structure. The separation is expected in the first half of 2028. It is meant to be tax-free to CVS Health and its shareholders for U.S. federal income tax purposes. It needs final approval from the board, an effective Form 10 registration statement with the U.S. Securities and Exchange Commission (SEC) and confirmation of the tax treatment. CVS shareholders will own shares in both companies. The company expects a solid investment grade rating for both, and dividends. The release states there is no assurance the split will happen, or on these terms.

Quarterly results. In a separate release CVS reported third quarter results. Revenue was $108.4 billion, up 5.4% from a year earlier. Adjusted EPS was $2.09, against $1.60. GAAP diluted EPS was $1.68, against a loss of $3.13 a year ago, when a $5.7 billion goodwill impairment hit. Full-year 2026 adjusted EPS guidance rose to at least $8.20 from a range of $7.90 to $8.10. CVS stays cautious because of elevated cost trends and possible macro headwinds.

Context. CNBC says the split would reverse the $78 billion Aetna deal of 2018. Shares have risen roughly 70% since Joyner took the helm in October 2024, and the company's market value is $117 billion. Leerink Partners analyst Michael Cherny called the news "a complete shock". He also suggested the reason could be to avoid state lawmakers' scrutiny of the company's vertical integration. That is his view, not the company's. PBMs now face criticism from both parties in Washington and from the states.

What we do not know. How the shares will behave, what financials and dividends each company will have, who will sit on the boards, and whether the timeline holds. This is an overview, not a forecast or advice.

Hechos confirmados

• On November 4, 2026 CVS Health announced it intends to separate into two independent, publicly traded companies. The decision follows a strategic review by the board of directors.^[1]
• One company will combine Aetna, CVS Caremark, CVS Specialty, Oak Street Health and Signify Health and will be called CVS Health for now. The other, CVS Pharmacy, will hold about 9,000 CVS pharmacies, mail pharmacy, MinuteClinic (including virtual care) and the Health100 technology services business.^[1]
• After the separation David Joyner will lead the company with Aetna and Caremark, and Prem Shah will be CEO of CVS Pharmacy. Other leaders and board members will be announced later.^[1]
• The separation is expected in the first half of 2028. It is intended to be tax-free to CVS Health and its shareholders for U.S. federal income tax purposes. Conditions include final board approval, an effective Form 10 registration statement with the SEC and confirmation of the tax treatment.^[1]
• CVS Health shareholders will own shares in both companies. Both are expected to have a solid investment grade rating and to pay dividends.^[1][3]
• Until the separation completes, CVS Health will keep operating as it does today. Customers, patients and clients will keep receiving medicine, care, benefits and services without interruption. The company says there is no assurance the separation will occur on the described terms or timeline.^[1]
• CVS Health third quarter 2026 revenue was $108.4 billion, up 5.4% year over year. Adjusted EPS was $2.09 against $1.60, and GAAP diluted EPS was $1.68 against a loss of $3.13.^[2]
• The prior-year loss reflects a $5.7 billion goodwill impairment charge in the third quarter of 2025.^[2]
• Full-year 2026 guidance was raised: adjusted EPS to at least $8.20 (from $7.90 to $8.10), GAAP diluted EPS to at least $6.98 (from $6.84 to $7.04), and cash flow from operations to at least $15.5 billion (from at least $11.5 billion).^[2]
• According to CNBC, the split would reverse the $78 billion Aetna acquisition of 2018. CVS shares have risen roughly 70% since October 2024, and the company's market value is $117 billion.^[3]
• Michael Cherny of Leerink Partners called the news "a complete shock" and suggested the rationale could be to avoid state lawmakers' scrutiny of the company's vertical integration.^[3]
• Pharmacy benefit managers (PBMs) face growing bipartisan scrutiny in Washington and in the states. Congress enacted PBM reforms in February.^[3]
• The Wall Street Journal reported that CVS has decided to split in two: one company with Aetna and Caremark, the other with its 9,000 retail pharmacies.^[4]

Implicaciones

• ConfirmadoCVS Health plans two separate public companies by the first half of 2028, subject to conditions.
• ConfirmadoCVS shareholders will own shares in both companies.
• Nuestra lecturaOne reason for the split may be pressure from lawmakers on vertical integration. This is the view of a Leerink Partners analyst, not a statement by the company.

Todavía no se sabe

• How the shares behave after the announcement and after the split
• What financials and dividends each company will have
• Who will sit on the boards
• Whether the split happens on time and as described

A quién afecta

USA, Global. People who follow CVS stock and U.S. healthcare

Fuentes

1. CVS Health: CVS Health Announces Intent to Create Two Distinct Leaders in Healthcare 4 de noviembre de 2026 · oficial
2. CVS Health: CVS Health Corporation Reports Third Quarter 2026 Results and Raises Full-Year 2026 Guidance 4 de noviembre de 2026 · oficial
3. CNBC: CVS to split off drugstore business in major breakup of healthcare giant 4 de noviembre de 2026 · medios
4. The Wall Street Journal: CVS Will Break Off Its Namesake Pharmacies 3 de noviembre de 2026 · medios